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Background: The SARS-CoV-2 pandemic in India has adversely affected many aspects of population health.
We need detailed evidence of the impact on reproductive health in India so that lessons can be learnt.
Methods: Hospital-based repeated monthly survey of nine severe maternal complications and death in 15
hospitals across five states in India covering a total of 202,986 hospital births, December-2018 through to
May-2021. We calculated incidence rates (with 95% confidence intervals (CIs)) per 1000 hospital births, case-
fatality and rate ratios (RR) with 95% CIs. Linear regression was used to examine the association between the
Government Response Stringency Index (GRSI) for India and changes in hospital births, incidence and
case-fatality.
Findings: There was a significant decrease in hospital births per month during the pandemic period with a
4.8% decrease per 10% increase in the GRSI scores (p < 0.001). The overall incidence of severe complications
in the pandemic period was not significantly different from the pre-pandemic period, but hospital admis-
sions from septic abortion was 56% higher (RR=1.56; 95% CI=1.221.99; p < 0.001). The overall case-fatality
of complications increased by 23% (RR=1.23; 95% CI=1.031.46; p = 0.022) and remained high across the dif-
ferent phases of the pandemic with a notable significant increase in deaths from heart failure in pregnancy.
Interpretation: Our study supports the legitimacy of the calls made to maintain sexual and reproductive
health services as essential services during the pandemic. Lessons learnt should be used to avert the ongoing
reproductive health crisis while India plans to manage a third wave of the pandemic.
Funding: The MaatHRI platform and this study are funded by a Medical Research Council Career Development
Award to MN (Ref:MR/P022030/1). The funder has no role in the study design, data collection, analysis, or
writing the paper
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The severe acute respiratory syndrome caused by the Coronavirus
2 (SARS-CoV-2) pandemic has claimed many lives across the world
with many countries going through a second or third wave of infec-
tion. India recently went through a devastating second wave which
started in March 2021. Until the end of May 2021, more than27 million cases and 315,000 deaths from SARS-CoV-2 infection have
been reported in India [1] and many fear that the actual numbers
could be higher. In addition to its direct impact on mortality and mor-
bidity, the pandemic has had significant indirect adverse effects on
many other aspects of population health including reproductive
health. A modelling study at the start of the pandemic predicted an
excess of 113,400 maternal deaths per annum globally considering a
scenario of severe impact on healthcare systems [2]. A recent system-
atic review found that maternal deaths increased by 37% during the
SARS-CoV-2 pandemic compared with the pre-pandemic period [3].
However, only three studies provided information about maternal
deaths, two from India [4,5] and one from Mexico [6] and the signifi-
cant increase estimated in the pooled analysis was driven by the
Mexico study alone. The two studies from India included a total of
4160 pregnancies during the pandemic and 11,512 pregnancies in
the pre-pandemic period [3]. One study found a 7% increase in
Research in context
Evidence before this study
Serious concerns have been raised about the impact of lock-
downs and restrictions on access to sexual and reproductive
health services with predicted rise in unsafe abortions and
decrease in access and demand for care. A recent systematic
review showed that maternal deaths increased by 37% during
the SARS-CoV-2 pandemic compared with the pre-pandemic
period. Existing studies from India are unable to provide
detailed evidence of the impact on reproductive health in the
country and the trends across the first and second waves.
Added value of this study
This is the first large study from a hospital-based repeated
monthly survey across five States in India comparing the inci-
dence and case-fatality of severe maternal complications in
202,986 births during the pandemic and pre-pandemic periods
over a duration of 30 months. The study not only demonstrates
a decrease in hospital births and a 23% increase in case-fatality
of severe maternal complications, it also showed a 56% increase
in hospital admissions from septic abortion during the pan-
demic period. Notably, septic abortion rate increased by two-
fold and 1.8-fold corresponding with the periods of rising first
and second waves, respectively.
Implications of all the available evidence
This study supports the legitimacy of the calls made by the
WHO, other international organisations and scientists to main-
tain sexual and reproductive health services as essential serv-
ices to continue to provide high quality care to avert rise in
maternal mortality and morbidity during the pandemic. While
India is preparing to manage a third wave of the pandemic, the
country needs to take urgent action to mitigate the ongoing
reproductive health crisis using the lessons learnt from the first
and second waves.
2 M. Nair et al. / EClinicalMedicine 39 (2021) 101063maternal deaths [5], but the other did not find an increase during the
pandemic compared with the pre-pandemic period [4]. The studies
only included data from the beginning of the first wave of the pan-
demic up to August 20204,5 and were unable to provide detailed evi-
dence of the impact of the pandemic on maternal mortality and
morbidity in India as the pandemic unfolded and the trends across
the first and second waves.
Serious concerns have been raised about the impact of lockdowns
and restrictions on access to sexual and reproductive health services
with a predicted rise in unsafe abortions [79] and decrease in access
and demand for care [2]. These concerns are especially relevant for
India, which has the second highest number of maternal deaths in
the world. However, the country has been making significant prog-
ress to reduce this high burden in recent years [10]. There is currently
a significant gap in understanding the impact of the pandemic on the
incidence and case-fatality of severe maternal complications and in
the trends of institutional births, which could be an indicator of
access to healthcare services. Addressing this knowledge gap will
help India, and other countries, in assessing the potential impact on
the progress made in reducing maternal deaths and accordingly
develop effective plans and health system interventions to mitigate
adverse effects. The recent systematic review did not find a signifi-
cant increase in gestational diabetes, pregnancy induced hyperten-
sion and postpartum haemorrhage in the pandemic compared with
the pre-pandemic period, but found a significant increase in surgicalmanagement of ruptured ectopic pregnancy [3]. The studies from
India did not report changes in the incidence and deaths due to
severe maternal complications.[4,5] Therefore, the objectives of this
study were to compare the incidence and case-fatality of severe life-
threatening maternal complications in India on a larger population
base between the SARS-CoV-2 pandemic and the pre-pandemic peri-
ods, and to examine trends across the two pandemic waves.
2. Methods
Study design: A hospital-based repeated monthly survey of severe
maternal complications and death is being undertaken through the
Maternal and perinatal Health Research collaboration, India (Maa-
tHRI) [11]. The survey has been ongoing since August 2018 in 15
selected public and private hospitals in five Indian states: Assam,
Maharashtra, Uttar Pradesh, Himachal Pradesh and Meghalaya. The
data included in this study covers a total of 202,986 hospital births
over a period of 30 months, December 2018 through to May 2021, 15
months pre-pandemic and 15 months during the pandemic. All co-
authors in the writing group had access to the data.
Data collection: A method tested in a pilot study in India [12] has
been employed to conduct an ongoing monthly survey of nine severe
maternal complications: (i) postpartum haemorrhage (PPH), (ii)
eclampsia, (iii) pre-eclampsia, (iv) septic abortion (sepsis following
spontaneous or induced abortion), (v) maternal peripartum infection
(not abortion related), (vi) uterine rupture, (vii) heart failure in preg-
nancy or postpartum, (viii) transient peripheral neuropathy during
pregnancy or postpartum and (ix) Japanese encephalitis. In addition,
hospitals are encouraged to report other severe complications not
included on the list. Standard definitions are used for each condition
(supplementary file, Table-S1). If a standard definition was not avail-
able for a particular condition, for example heart failure and transient
peripheral neuropathy in pregnant or postpartum women, a working
definition was developed by expert clinicians in conjunction with the
study collaborators and MaatHRI steering committee [11]. In cases of
multiple co-morbidities, the primary complication is ascertained,
which is defined as the complication that led to other co-morbidities.
For example, if a woman had sepsis that led to disseminated intravas-
cular coagulation (DIC) and ultimately death from haemorrhage, the
primary maternal complication was recorded as Sepsis.
Data on the number of clinically confirmed cases and deaths due
to each condition and total number of births are collected monthly
from the hospital records by a research nurse and reported through
an electronic case reporting system. Completeness is ensued through
‘nil’ reporting. A copy of the case notification form is included in the
supplementary file (Appendix-1). During a few months at the start of
the pandemic in March 2020, there was a slight delay in reporting,
but the reports were always complete and data quality checks were
done every month to identify any inaccuracies.
The reporting period from December 2018 to May 2021 was
divided into pre-pandemic (Dec-18 to Feb-2020) and pandemic
(Mar-20 to May-21) periods based on the data from the Johns Hop-
kin’s Resource Centre pertaining to the Coronavirus pandemic waves
in India [1]. Using this information, the pandemic period was further
divided into three phases: ‘pandemic-wave1 rising (Mar-Sep 2020)’,
‘pandemic-wave1 receding (Oct20-Feb21)’ and ‘pandemic-wave2 ris-
ing (Mar-May 2021)’. We used the time series data on the Govern-
ment Response Stringency Index (GRSI) for India, January 2020
through to May 2021, to calculate monthly average GRSI scores and
average scores corresponding with the phases of the pandemic wave.
The GRSI is a daily score computed since January 2020 by the Blavat-
nik School of Government at the University of Oxford (Oxford, UK)
based on the strictness of lockdown and restrictions implemented by
a given country to mitigate SARS-CoV-2 outbreaks [13].
Statistical analysis: Incidence rates were defined as the number of
new severe maternal complications in the study hospitals per 1000
M. Nair et al. / EClinicalMedicine 39 (2021) 101063 3hospital births over a given period of time, and Poisson incidence
rates (with 95% Confidence Intervals (CIs)) [14] were calculated.
Case-fatality was defined as the proportion of women with newly
diagnosed severe maternal complications who died within a given
time-period (i.e. the number died as a proportion of the number
newly diagnosed), and reported as percentage of cases with 95% CIs.
Incidence and case-fatality were calculated for overall complications
and individually for the following specific complications: (i) PPH, (ii)
eclampsia, (iii) pre-eclampsia, (iv) maternal peripartum infection, (v)
septic abortion, (vi) uterine rupture, (vii) heart failure in pregnancy
or postpartum, and (viii) others which included transient peripheral
neuropathy during pregnancy or postpartum, Japanese encephalitis,
and other severe complications such as antepartum haemorrhage,
pulmonary oedema, jaundice in pregnancy, gestational diabetes mel-
litus, and ruptured ectopic pregnancy. Due to small numbers, tran-
sient peripheral neuropathy and Japanese encephalitis were grouped
along with the other complications.
We calculated the percentage change in hospital births per month
during the pandemic period compared with the same calendar
month in the preceding pre-pandemic period. Linear regression
accounting for time-period was used to examine the association
between GRSI scores and change in hospital births, overall incidence
and case-fatality per month. Fractional polynomials were used to
examine the presence of non-linear associations between GRSI scores
and the outcome variables. Appropriateness of the linear models
were further examined by plotting the residuals. The b-coefficients
and GRSI scores were scaled to interpret the results as ‘per 10%’
increase in the GRSI scores.
We compared the incidence and case-fatality in the pandemic
period with the pre-pandemic period by calculating rate ratios (RR)
with 95% CIs and also graphically plotted the rates against the aver-
age GRSI score for the corresponding phase. RR with 95% CIs for over-
all and specific incidence and case-fatality were calculated to
compare each phase of the pandemic wave with the pre-pandemic
period. Where there were small number of events we did not calcu-
late incidence and case-fatality rates within States, but we conducted
sub-group analysis to examine the trends across the five States. All
analyses were adjusted for clustering at the level of the hospitals
using Robust Standard Errors. Results were considered to be signifi-
cant at a p-value of <0.05. Stata version 16.1 SE (StataCorp, College
Station, Texas) was used to conduct all analyses and graphs were
plotted using Microsoft Excel.
2.1. Ethics approval
The MaatHRI platform and the repeated monthly survey have
been approved by the institutional review boards (IRB) of each coor-
dinating Indian institution, namely: Srimanta Sankaradeva UniversityFig. 1. Change in hospital births in the pandemic period compared with the same mont
scores, January 2020* through May 2021) in India. Data source for the change in births: M
(GRSI) developed by the Blavatnik School of Government at the University of Oxford (Oxfordof Health Sciences, Guwahati, Assam (No.MC/190/2007/Pt-1/126);
Nazareth hospital, Shillong, Meghalaya (Ref No. NH/CMO/IEC/COM-
MUNICATIONS/18-01); Emmanuel Hospital Association, New Delhi
(Ref. Protocol No.167); Mahatma Gandhi Institute of Medical Scien-
ces, Sevagram, Maharashtra (Ref No. MGIMS/IEC/OBGY/118/2017);
and the Institute of Medical Sciences, Banaras Hindu University, Vara-
nasi, Uttar Pradesh (No.Dean/2018/EC/290). The project has also been
approved by the Government of India’s Health Ministry’s Screening
Committee, the Indian Council of Medical Research, New Delhi (ID
number 2018-0152) and by the Oxford Tropical Research Ethics Com-
mittee (OxTREC), University of Oxford, UK (OxTREC Ref: 718).
Patient/ participant consent: Not applicable as these are aggregate
numbers of cases and deaths from hospital records.
Role of the funding source: The MaatHRI platform and this study
are funded by a Medical Research Council Career Development
Award to MN (Ref:MR/P022030/1). The funder has no role in the
study design, data collection, analysis, or writing the paper.
3. Results
There were 202,986 hospital births during the 30 months of the
study period; 113,140 in the 15 months of the pre-pandemic period
and 89,846 in the 15 months of the pandemic period. A total of
24,109 women were admitted with at least one of the nine surveyed
severe maternal complications and a further 869 with other severe
complications over the 30 months. A total of 1020 women in the
study population died. Thus, the overall incidence rate for severe
maternal complications in the 15 hospitals across the five Indian
States was 123.05 per 1000 hospital births (95% CI 90.40 to 167.51)
and about 1 in 25 women who presented with a complication died
(case-fatality 4.08%, 95% CI 2.87 to 5.81).
There was a significant decrease in hospital births per month dur-
ing the pandemic compared with the same month in the preceding
pre-pandemic period (Fig. 1). The study showed that births in the 15
study hospitals across five states in India decreased by 4.8% per 10%
increase in the Indian Government Response Stringency Index
(GRSI). (p < 0.001). Hospital births decreased by more than 30% dur-
ing the start of the first wave of the pandemic and increased gradu-
ally towards the end of the first wave, but decreased again during the
ongoing second wave with more than a 35% decrease in May 2021
compared with May 2020. Hospital births never reached the pre-pan-
demic levels since the start of the pandemic and social restrictions in
March 2020. There was also a statistically significant positive linear
association between the GRSI scores and overall incidence rate driven
mainly by the decrease in hospital births (change in incidence of 3.3
per 1000 births per 10% increase in GRSI scores, 95% CI 1.5 to 5.5 per
1000 births, p = 0.002). The case-fatality was not significantly associ-
ated with the GRSI scores (change in case-fatality of 0.2% per 10%h in the preceding pre-pandemic period compared with the stringency index (GRSI
aatHRI; Data source for the Stringency index: Government Response Stringency Index








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4 M. Nair et al. / EClinicalMedicine 39 (2021) 101063increase in GRSI scores, 95% CI 0.1% to 0.4%, p = 0.120) (Figs. S1 and
S2, supplementary file). We did not find significant non-linear associ-
ations between the GRSI scores and the outcome variables and the
plotted residuals from the regression analyses showed a normal dis-
tribution suggesting a linear association.
Comparing the pandemic period with the pre-pandemic period
(Table-1) showed that the overall incidence of maternal complica-
tions increased from 117.93 per 1000 to 129.50 per 1000 hospital
births (RR = 1.10, 95% CI = 0.891.36, p = 0.386), and the trend was
similar across the five study States. The overall case-fatality increased
by 23% (RR = 1.23, 95% CI = 1.031.46, p = 0.022) from 3.69% in the
pre-pandemic period to 4.53% in the pandemic period, but the case-
fatality was mainly significantly higher in Assam (RR = 1.26; 95%
CI = 1.061.50; p = 0.011). The RR for case-fatality in Uttar Pradesh
was 1.78; 95% CI = 0.963.28; p = 0.065 and in the other three States
was 0.38; 95%CI = 0.121.21; p = 0.102. Although the overall inci-
dence rate in the pandemic period was not statistically significantly
higher than the incidence in the pre-pandemic period, the incidence
rate of septic abortion was 56% higher (RR = 1.56, 95% CI = 1.221.99,
p < 0.001). There was a 24% increase in the total number of hospital
admissions for septic abortion cases during the pandemic period
compared with the pre-pandemic period. There was a statistically
significant linear association between incidence of septic abortion
and GRSI scores with a change in incidence of 1.2 per 1000 births per
10% increase in GRSI scores, 95% CI 0.2 to 2.3 per 1000 births,
p = 0.022. We also found a two-fold increase in the case-fatality for
heart failure increasing from 28.9 to 58.2% (RR = 2.01, 95%
CI = 1.532.65, p < 0.001).
A detailed examination of the phases of the pandemic period
(wave-1 rising, wave-1 receding and wave-2 rising) showed that
compared with the pre-pandemic period, the overall incidence of
severe maternal complications increased significantly by 22% when
the first wave was rising; p-value = 0.044 (Fig.-2) and followed
closely with the average GRSI scores for the different phases of the
pandemic. The incidence rates were not significantly different from
the pre-pandemic rates for the other two phases of the pandemic; p-
values 0.843 and 0.944 for wave-1 receding and wave-2 rising,
respectively (Fig.-2). With regard to specific complications, the inci-
dence rates did not differ across the phases of the pandemic com-
pared with the pre-pandemic period except for septic abortion rates
which were two-fold higher than the pre-pandemic rates during
wave-1 rising (RR = 2.18; 95% CI = 1.662.85, p < 0.001) with a simi-
lar trend during wave-2 rising with only 3 months of data available
(Fig.-3).
The case-fatality figures were 2028% higher across the phases of
the pandemic compared with the pre-pandemic period (Fig.-2) and
remained high despite a decrease in the GRSI scores (Fig.-4). These
were not statistically significantly higher during wave-1 receding
and wave-2 rising possibly due to the smaller sample. Case-fatality
varied across the categories for heart failure during pregnancy or
postpartum (Table-2), being significantly higher across all phases of
the pandemic compared with the pre-pandemic period; p < 0.001 for
wave-1 rising and receding and p = 0.001 for wave-2 rising. Case-
fatality for uterine rupture was nearly 2.5 times higher during wave-
2 rising compared with the pre-pandemic period (RR = 2.47, 95%
CI = 0.996.17, p = 0.053).
4. Discussion
The study showed a fall in hospital births by about 5% per 10%
increase in stringency index (GRSI scores). The overall hospital-level
incidence rate for severe maternal complications increased by 10% in
the pandemic period compared with the pre-pandemic period, but
this was mainly driven by a significant increase in rate of hospital
admissions from septic abortion, which was two-fold higher during
the first and second waves of the pandemic. The overall hospital
Fig. 2. Hospital-based incidence and case-fatality of severe maternal complications during the pandemic waves compared with the pre-pandemic period in India (December 2018
through May 2021).
M. Nair et al. / EClinicalMedicine 39 (2021) 101063 5case-fatality increased by 23% compared with the pre-pandemic
period and remained high across the different phases of the pan-
demic. There was a notably high rate of death amongst women with
uterine rupture and heart failure during pregnancy or postpartum.
The decrease in hospital births corresponding with an increase in
stringency index suggests that lockdown and other restrictions had a
strong negative impact on institutional birth in the study settings in
India. This conforms to the findings of two previous studies by
Kumari et al [5]. and Goyal et al. [4], each in a single tertiary hospital
in India, which respectively reported a 43% and 45% reduction in hos-
pital births during the first wave of the pandemic compared with the
pre-pandemic period. This has serious implications for access to care
at childbirth and threatens to reverse the gains made in increasing
institutional births and access to emergency obstetric services in
India, [15] which are important determinants to reduce maternal
mortality.
There was no observed significant change in the incidence of
severe maternal complications, except septic abortion, during theFig. 3. Incidence of septic abortion across the phases of the pandemic in India, Decembe
across the phases of the pandemic, p-value <0.001; Change in incidence of septic abortion b
0.2 to 2.3 per 1000 births, p = 0.022; Data source for the incidence of septic abortion: MaatHR
developed by the Blavatnik School of Government at the University of Oxford.pandemic period. We observed a decrease in the overall number of
cases (except septic abortion) and hospital births; it seems likely that
mostly very sick women were coming to hospital. The relative
increase in case-fatality was due to an increase in deaths from all sur-
veyed complications, heart failure being significantly higher. Case-
fatality increased during the start of the first wave and remained
high throughout the different phases of the pandemic irrespective of
the stringency index/GRSI scores in India. Kumari et al [5]. found a 7%
increase in maternal deaths in a tertiary hospital during the strict
lockdown period in wave-1, but Goyal et al [4]. did not find any sig-
nificant increase during the first phase of the pandemic. The system-
atic review did not find any association between maternal, perinatal
and neonatal outcomes and the GRSI scores, and concluded that
stringent government response had no effect, rather the increase in
adverse outcomes were attributed to inefficiency of healthcare sys-
tems [3]. In contrast to other studies that covered a short duration of
the pandemic, our study presents the effects across different phases
of the pandemic and restrictions over a longer duration in a muchr 2018 through May 2021. Test for heterogeneity in incidence rates of septic abortion
y 1.2 per 1000 births per 10% increase in GRSI scores after accounting for time, 95% CI
I; Data source for the Stringency index: Government Response Stringency Index (GRSI)
Fig. 4. Case-fatality of severe maternal complications across the phases of the pandemic in India, December 2018 through May 2021. Test for heterogeneity in case-fatality
across the phases of the pandemic, p-value = 0.103;Change in case-fatality of 0.2% per 10% increase in GRSI scores after accounting for time, 95% CI 0.1% to 0.4%, p = 0.120;Data
source for case-fatality: MaatHRI; Data source for the Stringency index: Government Response Stringency Index (GRSI) developed by the Blavatnik School of Government at the Uni-
versity of Oxford.
6 M. Nair et al. / EClinicalMedicine 39 (2021) 101063larger sample of 202,986 hospital births. The evidence generated here
suggests that the negative impacts on maternal and reproductive
health was much higher during the rising first wave corresponding
with the period of strictest lockdown and major disruptions in India
and a similar trend can be seen during the ongoing second wave.
The high case-fatality could be due to a number of factors, including
reductions in healthcare providers and medical supplies as a result of
reallocation tomitigate the SARS-CoV-2 pandemic or a decrease in access
and/or demand for healthcare services [2]. While the quality of care in
the hospitals during the pandemic could have been compromised due to
shortage of healthcare staff, converting hospital wards into SARS-CoV-2
treatment Units, and other administrative challenges [16] we cannot
ignore access and demand as being a major risk factor for the increase in
maternal deaths in the hospitals both due to a lack of transportation dur-
ing lockdowns and ‘hospital-avoiding’ behaviour by pregnant women
suggested by other studies [4,5,17].
The negative impact of the pandemic and related restrictions on
sexual and reproductive health has been further demonstrated by an
increase in hospital admission rates of septic abortion confirming the
fears about increase in unsafe abortion raised by international organi-
sations like the International Federation of Gynaecology and Obstet-
rics (FIGO) [8] and Marie Stopes International[7] at the start of the
pandemic. Unsafe abortion is the third leading cause of maternal
mortality in India [7]. In a previous study covering nine states in
India, we found that two-thirds of the abortions were unsafe [18]. An
overall 56% increase in the rate of septic abortion with a two-fold
increase corresponding with the periods of rising first and second
waves suggest that access to safe abortion services were further com-
promised during the pandemic, particularly during the periods of the
strictest lockdown in India. Evidence related to incidence of severe
maternal complications from the other two studies were mixed, with
Goyal et al [4]. reporting 7% increase in hospital admissions of
high-risk pregnancies and Kumari et al [5]. reporting 66%
decrease in obstetric emergencies. We did not find any study
from India that specifically examined the incidence and deaths
from unsafe abortion during the pandemic. The estimated 23%
increase in deaths from severe maternal complications and two-
fold increase in hospital admissions from septic abortion observed
in the study hospitals are only the tip of the ice-berg. The overall
maternal mortality and morbidity rates in hospitals and commu-
nities could be much higher.This is the first large study from a hospital-based survey across
five states in India comparing the incidence and case-fatality of
severe maternal complications in more than 202,000 births during
the pandemic and pre-pandemic periods over a duration of 30
months. We were also able to compare the trends across the different
phases of two waves of the pandemic. We did not have information
on maternal hospital admissions and death rates due to complica-
tions other than those included in the study, therefore the reported
case-fatality do not reflect the overall maternal mortality rate in the
population. We also did not have additional information about SARS-
CoV-2 infection in the cases and deaths included in the study, and
therefore cannot ascertain any additional effect of this co-morbidity
on case-fatality. This was beyond the scope of this paper and further
epidemiological studies are required to delineate the effect.
We acknowledge that given the rarity of most of the outcomes
explored, there are limits to the statistical power to detect small
changes in these outcomes. Although we had a large sample of hospi-
tal births, the number of cases and deaths for each condition was still
small which together with accounting for clustering limited the
power to detect statistically significant RR. It is important to note
that our study hospitals are from five States in India with a varying
pre-existing burden of maternal mortality. The relative increase in
case-fatality was higher in the two states that have a high burden
(Assam and Uttar Pradesh) than the three that have a lower burden
(Meghalaya, Maharashtra and Himachal Pradesh) [19], thus the over-
all rate would be generalizable to the country. Furthermore, the col-
laborating hospitals are both from the public and the private sectors.
A majority are tertiary level referral facilities except two which are
community level hospitals. These are representative of the different
types of referral hospitals that cater to the population across India.
Further details about the study hospitals can be found in the MaatHRI
methodology paper [11] and current updates are available on the
MaatHRI website https://www.npeu.ox.ac.uk/maathri.
Our study supports the legitimacy of the calls made by the WHO,
other international organisations and scientists to maintain sexual
and reproductive health services as essential services to continue to
provide high quality care in order to avert rise in maternal mortality
and morbidity during the pandemic [7,8]. The evidence supports the
recommendations made by other studies in India to encourage
women to seek timely care by alleviating fears of catching SARS-CoV-










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































M. Nair et al. / EClinicalMedicine 39 (2021) 101063 7manage a third wave of the pandemic, the country needs to take
urgent action to mitigate the ongoing reproductive health crisis using
the lessons learnt from the first and second waves. Special transport/
ambulance services could be made available for pregnant women
during periods of lockdowns together with active public health mes-
saging urging women to seek required reproductive health care
including safe abortion services. Since 2000, there has been an esti-
mated 5.5% average annual decline in the maternal mortality ratio in
India [20], but if the observed trend of 2028% increase in case-fatal-
ity continues, it could push back the progress made by several years.
Furthermore, there are wider implications of the pandemic on repro-
ductive health affecting access to safe abortion services, and if
allowed to continue, could lead to devastating consequences for
thousands of women, their families, and the society. It will hinder
and most likely reverse the progress made in achieving the Sustain-
able Development Goal of reducing maternal mortality in India and
globally.
The MaatHRI collaboration will continue to monitor the effects of
the pandemic on the incidence and case-fatality of severe maternal
complications in the 15 hospitals across the country and updates on
the trend will be henceforth disseminated regularly through the
MaatHRI quarterly newsletter available through https://www.npeu.
ox.ac.uk/maathri/newsletters.Author contributions
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